The risk and incidence of vascular disease in patients with non-insuli
n-dependent diabetes mellitus (NIDDM) are higher than those of the non
diabetic population. The modest changes in the concentration of plasma
lipids that have been reported do not fully explain this increased ri
sk of vascular disease in diabetics. However, there have been numerous
reports of changes in the composition and structure of plasma lipopro
teins in patients with NIDDM that render these lipoproteins more ather
ogenic. Changes in the subpopulation distribution of plasma low-densit
y lipoprotein and high-density lipoprotein, which have been shown to b
e associated with vascular disease, have been also observed in patient
s with NIDDM. Although the precise mechanisms that underlie the origin
ation of alterations in the subpopulation distribution of plasma lipop
roteins have not been fully elucidated, evidence strongly suggests tha
t changes in the activities of key enzymes in lipoprotein metabolism m
ay contribute to the altered lipoproteins. This review describes the e
ffects of diabetes, along with the confounding effects of obesity and
insulin resistance, on the metabolism of plasma lipoproteins. in addit
ion, the changes in the function of enzymes that are involved in the m
etabolism of cholesterol and triglycerides of circulating lipoproteins
that occur in NIDDM are presented. Although new insight on the effect
s of diabetes and its complications on the metabolism of lipoproteins
has been gained, there are still gaps that need to be filled to comple
te our understanding of the strong relationship between diabetes and v
ascular disease. (C) Elsevier Science Inc.